Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Plos Pathogens|April 22, 2026
Physiologic recovery of Mycobacterium tuberculosis from drug injury: A molecular study of post antibiotic effect in vitro and in vivoJo Hendrix, Reem Al Mubarak, Matthew J Reichlen, et al.
Journal of Medicinal Chemistry|February 17, 2022
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial PathogensZhenkun Ma, Shijie He, Ying Yuan, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2023
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis modelMichelle E Ramey, Firat Kaya, Allison A Bauman, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2023
Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responsesNicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.
ACS Infectious Diseases|September 21, 2021
Preclinical Evaluation of Inhalational Spectinamide-1599 Therapy against TuberculosisMercedes Gonzalez-Juarrero, Pradeep B Lukka, Santosh Wagh, et al.
ACS Infectious Diseases|January 14, 2017
Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance ContributionsJiuyu Liu, David F Bruhn, Robin B Lee, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832Gregory T Robertson, Michelle E Ramey, Lisa M Massoudi, et al.
Life Science Alliance|November 21, 2018
Discovery of a cofactor-independent inhibitor of <i>Mycobacterium tuberculosis</i> InhAYi Xia, Yasheen Zhou, David S Carter, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Transcriptional adaptation of drug-tolerant <i>Mycobacterium tuberculosis</i> in miceElizabeth A Wynn, Christian Dide-Agossou, Matthew Reichlen, et al.
Pageof 8